Similar articles

• Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats.

  Cook JD, Davis BJ, Goewey JA, Berry TD, Walker CL. Cook JD, et al. Reprod Sci. 2007 Feb;14(2):121-36. doi: 10.1177/1933719106298401. Reprod Sci. 2007. PMID: 17636224
• Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol.

  Greathouse KL, Cook JD, Lin K, Davis BJ, Berry TD, Bredfeldt TG, Walker CL. Greathouse KL, et al. Reprod Sci. 2008 Oct;15(8):765-78. doi: 10.1177/1933719108322440. Reprod Sci. 2008. PMID: 19017814
• An in vivo/in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyoma.

  Hodges LC, Hunter DS, Bergerson JS, Fuchs-Young R, Walker CL. Hodges LC, et al. Ann N Y Acad Sci. 2001 Dec;948:100-11. doi: 10.1111/j.1749-6632.2001.tb03991.x. Ann N Y Acad Sci. 2001. PMID: 11795388 Review.
• Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis.

  Miller C, Degenhardt K, Sassoon DA. Miller C, et al. Nat Genet. 1998 Nov;20(3):228-30. doi: 10.1038/3027. Nat Genet. 1998. PMID: 9806537 Free PMC article. No abstract available.
• Uterine leiomyomas: mechanisms of tumorigenesis.

  Houston KD, Hunter DS, Hodges LC, Walker CL. Houston KD, et al. Toxicol Pathol. 2001 Jan-Feb;29(1):100-4. doi: 10.1080/019262301301418900. Toxicol Pathol. 2001. PMID: 11215673 Review.